Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.
Investor's Business Daily on MSN
This once-deflated cloud stock deserves another look. Here's why.
A collaboration with Amazon and a potential breakout are just two of the factors putting Snowflake stock on investors' radar.
Tesla Q2 2026 deliveries hit a record, but TSLA slides as analysts split on valuation, FSD/robotaxi and China risks.
The World Cup semifinals are set, with Spain, England, Argentina and France making up the chalkiest final four in tournament ...
The corporate treasury function traditionally involves ensuring liquidity for operations and managing financial risk to the ...
The coolest semiconductor chip startup companies of 2026 innovating tech hardware are Axelera AI, Tenstorrent, NextSilicon, ...
We examine how AI is changing the future of work — and how, in many ways, that future is already here. Every tech company you can think of is jumping on the generative AI bandwagon and touting new ...
Ripple (XRP) remains in a dominant bearish trend, trading at $10.08 as of Monday. This marks the third straight day the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果